Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00008437 · ClinicalTrials.gov registry record · Phase 2
MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer
A Phase 2 study, sponsored by InSightec.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00008437 is a Phase 2 study that has completed, run by InSightec.
The verdict
NCT00008437, a Phase 2 study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Imaging procedures, such as MRI, may allow the doctor to better detect the tumor. Highly focused ultrasound energy may be able to kill tumor cells by heating the breast tumor cells without affecting the surrounding tissue. PURPOSE: Phase II trial to study the effectiveness of MRI-guided ultrasound energy in treating women who have stage I, stage II, or stage IIIA breast cancer.
Interventions
- DEVICE high-intensity focused ultrasound ablation
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-12 |
| Est. Completion | 2000-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00008437
The ClinicalTrials.gov registry entry for NCT00008437 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which high-intensity focused ultrasound ablation is the first listed.
NCT00008437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00008437 about?
NCT00008437 is a clinical study titled "MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer". RATIONALE: Imaging procedures, such as MRI, may allow the doctor to better detect the tumor. Highly focused ultrasound energy may be able to kill tumor cells by heating the breast tumor cells without affecting the surrounding tissue. PURPOSE: Phase II trial to study the effectiveness of MRI-guided ...
What is the current status of trial NCT00008437?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-12. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00008437?
The interventions under investigation include: high-intensity focused ultrasound ablation (DEVICE).
Who is sponsoring clinical trial NCT00008437?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.